Most health expert recommend six month of exclusive breastfeeding but statics suggest that numbers are not good, almost 95% mothers start breastfeeding but this number drops to 40% in first three month and further it drops to 15% till fifth month. Sometime its due to need of medication usage. Because of these statics its important to provide good information on safety of drugs in breastfeeding so that it can be improved when possible. In this FAQ sheet we will discuss about exposure to Neulasta | Pegfilgrastim Kit while breastfeeding. We will also discuss about common side effects and warnings associated with Neulasta | Pegfilgrastim Kit.
What is Neulasta | Pegfilgrastim Kit used for?
Neulasta is a leukocyte growth factor indicated to Decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia. (1.1) Increase survival in patients acutely exposed to myelosuppressive doses of radiation (Hematopoietic Subsyndrome of Acute Radiation Syndrome). (1.2) Limitations of Use Neulasta is not indicated for the mobilization of peripheral blood progenitor cells for hematopoietic stem cell transplantation. 1.1 Patients with Cancer Receiving Myelosuppressive Chemotherapy Neulasta is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia [ see Clinical Studies ( 14.1 ) ]. Limitations of Use Neulasta is not indicated for the mobilization of peripheral blood progenitor cells for hematopoietic stem cell transplantation. 1.2 Patients with Hematopoietic Subsyndrome of Acute Radiation Syndrome Neulasta is indicated to increase survival in patients acutely exposed to myelosuppressive doses of radiation [see Dosage and Administration ( 2.2 ) and Clinical Studies ( 14.2 )].
I am breastfeeding mother and I am using Neulasta | Pegfilgrastim Kit. Can it have any bad effect on my kid? Shall I search for better alternative?
As per our analysis Neulasta | Pegfilgrastim Kit contains only one ingredient and that is Pegfilgrastim. We have analyzed Pegfilgrastim and it seems to be safe to use Pegfilgrastim while breastfeeding, that means usage of Neulasta | Pegfilgrastim Kit shall be safe while breastfeeding. Below you can check more details of Pegfilgrastim usage in breastfeeding. We recommend you to go through provided detailed analysis as below take decision accordingly.
Neulasta | Pegfilgrastim Kit Breastfeeding Analsys
SafeCAS Number: 208265-92-3
Non-glycosylated stimulating factor of granulocyte colonies (G-CSF) which is obtained by recombinant technology.The naturally occurring product is found in breast milk. A very high molecular weight explains the insignificant or no excretion into milk that has been observed both with Lenograstim and Filgrastim. Its low oral bioavailability hampers absorption into infant plasma from the breast milk ingested, as for their proteic nature it is degraded in the gastrointestinal tract, not being absorbed. Filgrastim is not absorbed by the infant's gut even during the neonatal period or prematurity. The granulocyte colony-stimulating factor has been used in premature newborns, both on prevention and treatment of neonatal sepsis and/or necrotizing enterocolitis without adverse effects being observed among treated infants. The bovine G-CSF is found in the usual diet of meat eaters.

What should I do if already breastfed my kid after using Neulasta | Pegfilgrastim Kit?
As usage of Neulasta | Pegfilgrastim Kit is mostly safe while breastfeeding hence there should not be any concern. In case of any change in behavior or health of your baby you should inform your health care provider about usage of Neulasta | Pegfilgrastim Kit else no further action is required.
I am nursing mother and my doctor has suggested me to use Neulasta | Pegfilgrastim Kit, is it safe?
Usage of Neulasta | Pegfilgrastim Kit is safe for nursing mothers and baby, No worries.
If I am using Neulasta | Pegfilgrastim Kit, will my baby need extra monitoring?
No
Who can I talk to if I have questions about usage of Neulasta | Pegfilgrastim Kit in breastfeeding?
US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week
Drug Brands with same Active ingredients